Fundraising Fox

BioROSA Technologies

Belmont, US · Founded 2018 · Delaware corporation · 3 employees on LinkedIn · 2 known investors

Founders & leadership

MC
Marie CauseyNamed on SEC filing
JS
John SlatteryNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$3.6M disclosed across 3 rounds · 2019–2022

$745KraisedNov 2022 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SlatteryExecutive Officer, Director
  • Christopher JeffersExecutive Officer, Director
  • Marie CauseyExecutive Officer, Director
Offering amount
$1.6M
Amount sold
$745K
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.4MraisedJul 2021 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SlatteryExecutive Officer, Director
  • Marie CauseyExecutive Officer, Director
Offering amount
$2.4M
Amount sold
$2.4M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$450KraisedJul 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marie CauseyExecutive Officer, Director
  • John SlatteryExecutive Officer, Director
Offering amount
$1M
Amount sold
$450K
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are BioROSA Technologies's investors?
BioROSA Technologies's investors include AUTISM IMPACT, IndieBio.
How much funding has BioROSA Technologies raised?
BioROSA Technologies has disclosed $3.6M raised across 3 rounds.
Where is BioROSA Technologies headquartered?
BioROSA Technologies is headquartered in Belmont, US.